Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1979 2
1980 2
1981 1
1982 2
1983 4
1984 5
1985 3
1986 3
1987 6
1988 2
1989 7
1990 8
1991 6
1992 7
1993 6
1994 3
1996 10
1997 8
1998 10
1999 10
2000 9
2001 11
2002 18
2003 10
2004 11
2005 12
2006 11
2007 9
2008 12
2009 8
2010 8
2011 4
2012 8
2013 5
2014 9
2015 8
2016 9
2017 6
2018 5
2019 2
2020 2
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

282 results
Results by year
Filters applied: . Clear all
Page 1
Heterogeneity of Melanoma with Stem Cell Properties.
Seftor EA, Margaryan NV, Seftor REB, Hendrix MJC. Seftor EA, et al. Among authors: hendrix mjc. Adv Exp Med Biol. 2019;1139:105-114. doi: 10.1007/978-3-030-14366-4_6. Adv Exp Med Biol. 2019. PMID: 31134497 Review.
Biological functions of maspin.
Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJ. Bailey CM, et al. Among authors: hendrix mj. J Cell Physiol. 2006 Dec;209(3):617-24. doi: 10.1002/jcp.20782. J Cell Physiol. 2006. PMID: 17001697 Review.
Heterogeneity and Plasticity of Melanoma: Challenges of Current Therapies.
Hendrix MJC, Seftor EA, Margaryan NV, Seftor REB. Hendrix MJC, et al. In: Ward WH, Farma JM, editors. Cutaneous Melanoma: Etiology and Therapy [Internet]. Brisbane (AU): Codon Publications; 2017 Dec 21. Chapter 4. In: Ward WH, Farma JM, editors. Cutaneous Melanoma: Etiology and Therapy [Internet]. Brisbane (AU): Codon Publications; 2017 Dec 21. Chapter 4. PMID: 29461776 Free Books & Documents. Review.
Nodal Signaling as a Developmental Therapeutics Target in Oncology.
Kalyan A, Carneiro BA, Chandra S, Kaplan J, Chae YK, Matsangou M, Hendrix MJC, Giles F. Kalyan A, et al. Among authors: hendrix mjc. Mol Cancer Ther. 2017 May;16(5):787-792. doi: 10.1158/1535-7163.MCT-16-0215. Mol Cancer Ther. 2017. PMID: 28468864 Free article. Review.
Maspin: molecular mechanisms and therapeutic implications.
Bodenstine TM, Seftor RE, Khalkhali-Ellis Z, Seftor EA, Pemberton PA, Hendrix MJ. Bodenstine TM, et al. Among authors: hendrix mj. Cancer Metastasis Rev. 2012 Dec;31(3-4):529-51. doi: 10.1007/s10555-012-9361-0. Cancer Metastasis Rev. 2012. PMID: 22752408 Review.
ATP11B mediates platinum resistance in ovarian cancer.
Moreno-Smith M, Halder JB, Meltzer PS, Gonda TA, Mangala LS, Rupaimoole R, Lu C, Nagaraja AS, Gharpure KM, Kang Y, Rodriguez-Aguayo C, Vivas-Mejia PE, Zand B, Schmandt R, Wang H, Langley RR, Jennings NB, Ivan C, Coffin JE, Armaiz GN, Bottsford-Miller J, Kim SB, Halleck MS, Hendrix MJ, Bornman W, Bar-Eli M, Lee JS, Siddik ZH, Lopez-Berestein G, Sood AK. Moreno-Smith M, et al. Among authors: hendrix mj. J Clin Invest. 2021 Apr 1;131(7):e149893. doi: 10.1172/JCI149893. J Clin Invest. 2021. PMID: 33792569 Free PMC article. No abstract available.
Intermediate filaments.
Hendrix MJ. Hendrix MJ. Cancer Metastasis Rev. 1996 Dec;15(4):413-6. doi: 10.1007/BF00054009. Cancer Metastasis Rev. 1996. PMID: 9034600 Review. No abstract available.
Targeting Nodal in malignant melanoma cells.
Postovit LM, Seftor EA, Seftor RE, Hendrix MJ. Postovit LM, et al. Among authors: hendrix mj. Expert Opin Ther Targets. 2007 Apr;11(4):497-505. doi: 10.1517/14728222.11.4.497. Expert Opin Ther Targets. 2007. PMID: 17373879 Review.
282 results